Revolve Wealth Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $399K | Buy |
3,595
+108
| +3% | +$12K | 0.05% | 139 |
|
|
2025
Q1 | $391K | Buy |
3,487
+196
| +6% | +$22K | 0.06% | 140 |
|
|
2024
Q4 | $304K | Buy |
3,291
+37
| +1% | +$3.42K | 0.04% | 164 |
|
|
2024
Q3 | $273K | Sell |
3,254
-56
| -2% | -$4.7K | 0.04% | 158 |
|
|
2024
Q2 | $227K | Sell |
3,310
-195
| -6% | -$13.4K | 0.04% | 156 |
|
|
2024
Q1 | $257K | Sell |
3,505
-102
| -3% | -$7.47K | 0.04% | 146 |
|
|
2023
Q4 | $292K | Buy |
3,607
+130
| +4% | +$10.5K | 0.06% | 122 |
|
|
2023
Q3 | $261K | Buy |
3,477
+192
| +6% | +$14.4K | 0.06% | 122 |
|
|
2023
Q2 | $253K | Sell |
3,285
-72
| -2% | -$5.55K | 0.06% | 122 |
|
|
2023
Q1 | $279K | Sell |
3,357
-236
| -7% | -$19.6K | 0.07% | 115 |
|
|
2022
Q4 | $308K | Buy |
3,593
+245
| +7% | +$21K | 0.09% | 104 |
|
|
2022
Q3 | $207K | Buy |
+3,348
| New | +$207K | 0.07% | 119 |
|
|
2022
Q1 | – | Sell |
-3,156
| Closed | -$229K | – | 151 |
|
|
2021
Q4 | $229K | Buy |
+3,156
| New | +$229K | 0.07% | 133 |
|